ArticleFuture oncology (London, England)2024

Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study.

Muhammad Furqan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.